Switch theme
Sign up to access all valuation multiples
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
2017
1.1K+
LTM Revenue $6.0B
LTM EBITDA -$123M
$594M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Agilon Health has a last 12-month revenue (LTM) of $6.0B and a last 12-month EBITDA of -$123M.
In the most recent fiscal year, Agilon Health achieved revenue of $6.1B and an EBITDA of -$218M.
Agilon Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Agilon Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $6.0B | XXX | $6.1B | XXX | XXX | XXX |
| Gross Profit | $166M | XXX | $4.8M | XXX | XXX | XXX |
| Gross Margin | 3% | XXX | 0% | XXX | XXX | XXX |
| EBITDA | -$123M | XXX | -$218M | XXX | XXX | XXX |
| EBITDA Margin | -2% | XXX | -4% | XXX | XXX | XXX |
| EBIT | -$183M | XXX | -$289M | XXX | XXX | XXX |
| EBIT Margin | -3% | XXX | -5% | XXX | XXX | XXX |
| Net Profit | -$211M | XXX | -$260M | XXX | XXX | XXX |
| Net Margin | -4% | XXX | -4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Agilon Health's stock price is $2.
Agilon Health has current market cap of $919M, and EV of $594M.
See Agilon Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $594M | $919M | XXX | XXX | XXX | XXX | $-0.50 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Agilon Health has market cap of $919M and EV of $594M.
Agilon Health's trades at 0.1x EV/Revenue multiple, and -2.7x EV/EBITDA.
Equity research analysts estimate Agilon Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Agilon Health has a P/E ratio of -4.4x.
See valuation multiples for Agilon Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $919M | XXX | $919M | XXX | XXX | XXX |
| EV (current) | $594M | XXX | $594M | XXX | XXX | XXX |
| EV/Revenue | 0.1x | XXX | 0.1x | XXX | XXX | XXX |
| EV/EBITDA | -4.8x | XXX | -2.7x | XXX | XXX | XXX |
| EV/EBIT | -3.2x | XXX | -2.1x | XXX | XXX | XXX |
| EV/Gross Profit | 3.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | -4.4x | XXX | -3.5x | XXX | XXX | XXX |
| EV/FCF | -6.8x | XXX | -6.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAgilon Health's last 12 month revenue growth is 3%
Agilon Health's revenue per employee in the last FY averaged $5.6M, while opex per employee averaged $0.3M for the same period.
Agilon Health's rule of 40 is 0% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Agilon Health's rule of X is 6% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Agilon Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | -2% | XXX | -4% | XXX | XXX | XXX |
| EBITDA Growth | -55% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 0% | XXX | 0% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 6% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $5.6M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Agilon Health acquired XXX companies to date.
Last acquisition by Agilon Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Agilon Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Agilon Health founded? | Agilon Health was founded in 2017. |
| Where is Agilon Health headquartered? | Agilon Health is headquartered in United States of America. |
| How many employees does Agilon Health have? | As of today, Agilon Health has 1.1K+ employees. |
| Who is the CEO of Agilon Health? | Agilon Health's CEO is Mr. Steven J. Sell. |
| Is Agilon Health publicy listed? | Yes, Agilon Health is a public company listed on NYS. |
| What is the stock symbol of Agilon Health? | Agilon Health trades under AGL ticker. |
| When did Agilon Health go public? | Agilon Health went public in 2021. |
| Who are competitors of Agilon Health? | Similar companies to Agilon Health include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Agilon Health? | Agilon Health's current market cap is $919M |
| What is the current revenue of Agilon Health? | Agilon Health's last 12 months revenue is $6.0B. |
| What is the current revenue growth of Agilon Health? | Agilon Health revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Agilon Health? | Current revenue multiple of Agilon Health is 0.1x. |
| Is Agilon Health profitable? | Yes, Agilon Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Agilon Health? | Agilon Health's last 12 months EBITDA is -$123M. |
| What is Agilon Health's EBITDA margin? | Agilon Health's last 12 months EBITDA margin is -2%. |
| What is the current EV/EBITDA multiple of Agilon Health? | Current EBITDA multiple of Agilon Health is -4.8x. |
| What is the current FCF of Agilon Health? | Agilon Health's last 12 months FCF is -$87.4M. |
| What is Agilon Health's FCF margin? | Agilon Health's last 12 months FCF margin is -1%. |
| What is the current EV/FCF multiple of Agilon Health? | Current FCF multiple of Agilon Health is -6.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
